{"raw_mentions": "There are no sentences that meet the specified criteria in the provided text snippet. The text appears to describe methods, applications, and potential uses of various molecules and assays, but it does not include specific numeric values with units for bioactivity metrics related to specific molecule names or identifiers."}
{"raw_mentions": "There are no sentences in the provided text that contain all four required components: a specific molecule name, ID or other identifier, a bioactivity metric, a specific numeric value for that metric, and a unit for that value. The text appears to be focused on the identification and characterization of molecules, particularly B7 and the molecule identified by the BB-1 monoclonal antibody, but does not include specific bioactivity metrics or numeric values with units."}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nThe labeled CTLA4-Ig (4 nM) was added to each well in the presence or absence of unlabeled competing Ig fusion proteins, including full-length B7-2 (hB7-2Ig), full-length B7-1 (hB7-1Ig), the variable region-like domain of B7-2 (hB7-2VIg) and the constant region-like domain of B7-2 (hB7-2CIg) and allowed to bind for 2.5 h at room temperature."}
{"final_json": [{"molecule_name": "CTLA4-Ig", "protein_target_name": null, "binding_metric": null, "value": "4", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "hB7-2Ig", "protein_target_name": null, "binding_metric": null, "value": null, "unit": null, "is_logarithmic": false}, {"molecule_name": "hB7-1Ig", "protein_target_name": null, "binding_metric": null, "value": null, "unit": null, "is_logarithmic": false}, {"molecule_name": "hB7-2VIg", "protein_target_name": null, "binding_metric": null, "value": null, "unit": null, "is_logarithmic": false}, {"molecule_name": "hB7-2CIg", "protein_target_name": null, "binding_metric": null, "value": null, "unit": null, "is_logarithmic": false}]}
{"raw_mentions": "Using this solid phase binding assay, the avidity of B7-2 (2.7 nM) for CTLA4 was determined to be approximately two-fold lower than that observed for B7-1 (4.6 mM).\nThe results, presented in FIG. 20, show that half-saturation occurred at 500 pM for B7-1Ig, and at \nThe ability of unlabelled B7-1Ig or B7-2Ig to compete with biotinylated B7-1Ig or B7-2Ig, respectively, was assessed by mixing varying amounts of the competing protein with a quantity of biotinylated B7-1Ig or B7-2Ig shown to be non-saturating (i.e., 70 ng/mL; 1.5 nM) and performing the binding assays as described above."}
{"final_json": [{"molecule_name": "B7-2", "protein_target_name": "CTLA4", "binding_metric": null, "value": "2.7", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "B7-1", "protein_target_name": "CTLA4", "binding_metric": null, "value": "4.6", "unit": "mM", "is_logarithmic": false}, {"molecule_name": "B7-1Ig", "protein_target_name": null, "binding_metric": "half-saturation", "value": "500", "unit": "pM", "is_logarithmic": false}, {"molecule_name": "B7-1Ig", "protein_target_name": null, "binding_metric": null, "value": "1.5", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "B7-1Ig", "protein_target_name": null, "binding_metric": null, "value": "70", "unit": "ng/mL", "is_logarithmic": false}]}
